The avidity of allospecific cytotoxic T lymphocytes (CTL) determines their cytokine production profile

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 447-453

  Van Emmerik, Nancy E M ^a   Daane, C R ^a   Knoop, C J ^a   Hesse, C ^a   Vaessen, L M B ^a   Balk, A H M M ^a   Mochtar, B ^a   Claas, F H J ^b   Weimar, W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Avidity; Cytokine; Interferon gamma; Transplantation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6;

ALLOGRAFT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL;

EID: 0030834553     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4441458.x     Document Type: Article

References (35)

1. Sutton R, Gray DWR, McShane P et al. The specificity of rejection and the absence of susceptibility of pancreatic islet B cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat. J Exp Med 1989; 170:751-62.
2. Mintz B, Silvers WK. 'Intrinsic' immunologic tolerance in allophenic mice. Science 1967; 158:1484-7.
3. Snider ME, Armstrong L, Hudson JL, Steinmuller D. In vitro and in vivo cytotoxicity of T cells cloned from rejecting allografts. Transplantation 1986; 42:171-7.
4. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ. CD4- positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56:892-7.
5. + T cells results in Th2 cytokine production and alternative mechanisms of allograft rejection. Transplantation 1995; 59:1155-61.
6. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165:566-71.
7. Weber T, Zerbe T, Kaufman C et al. Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Transplantation 1989; 48:430.
8. Ouwehand AJ, Baan CC, Roelen DL et al. The detection of cytotoxic T cells with high affinity receptors for donor antigens in the transplanted heart as prognostic factor for graft rejection. Transplantation 1993; 56:1223-9.
9. Vaessen LMB, Baan CC, Ouwehand AJ et al. Differential avidity and cyclosporin sensitivity of committed donor-specific cytotoxic T cells and their precursors. Transplantation 1994; 57:1051-9.
10. van Emmerik NEM, Loonen EHM, Vaessen LMB et al. The avidity, not the mere presence, of primed CTL for donor HLA class II antigens determines their clinical relevance after heart transplantation. J Heart Lung Transplant 1997; 16:240-9.
11. MacDonald HR, Glasebrook AL, Bron C, Kelso A, Cerottini J-C. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev 1982; 68:89-115.
12. Marrack P, Endres R, Shimonkevitz R et al. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4, product. J Exp Med 1983; 158:1077-91.
13. Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding. J Exp Med 1984; 159:783-97.
14. De Vries JE, Yssel H, Spits H. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes. Immunol Rev 1989; 109:119-41.
15. Maryanski JL, Pala P, Cerottini J-C, Macdonald HR. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen. Eur J Immunol 1988; 18:1863-6.
16. Auphan N, Curnow J, Guimezanes A et al. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR- transgenic mice. Eur J Immunol 1994; 24:1572-7.
17. Kim DT, Rothbard JB, Bloom DB, Fathman CG. Quantitative analysis of T cell activation. Role of TCR/ligand density and TCR affinity. J Immunol 1996; 156:2737-42.
18. Al-Ramadi BK, Jelonek MJ, Boyd LF, Margulies DH, Bothwell ALM. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J Immunol 1995; 155:662-73.
19. Van Emmerik NEM, Vaessen LMB, Balk AHMM, Bos E, Claas FHJ, Weimar W. Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection. Transplantation 1996; 62:529-36.
20. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- and low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 1996; 93:4102-7.
21. Romagnani S. Short analytic review. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80:225-35.
22. Baan CC, van Emmerik NEM, Balk AHMM et al. Cytokine mRNA expression in endomyocard biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994; 97:293-8.
23. Kupiec-Weglinski JW, Wasowska B, Papp I et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151:5053-61.
24. Mottramm PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL- 2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59:559-65.
25. Egawa H, Martinez OM, Quinn MB et al. Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation 1995; 59:97-102.
26. Fallarino F, Uyttenhove C, Boon T, Gajewski TF. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J Immunol 1996; 156:1095-100.
27. Brillhart KL, Ngo TT. Use of microwell plates carrying hydrazide groups to enhance antibody immobilization in enzyme immunoassays. J Immunol Methods 1991; 144:19-25.
28. Halloran P, Batiuk T, Goes N. An overview of the cytokines in transplantation. Transplant Sci 1993; 3:69-76.
29. Roelen DL, van Beelen E, van Bree FPMJ, van Rood JJ, Volker-Dieben HJ, Claas FHJ. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation 1995; 59:1039-42.
30. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-74.
31. Kumar V, Bhardwaj V, Soares L, Alexander J, Sette A, Sercarz E. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon by T cells. Proc Natl Acad Sci USA 1995; 92:9510-4.
32. + T cells. J Exp Med 1995; 182:1591-6.
33. + T lymphocytes. J Immunol 1993; 151:5993-6001.
34. Cai Z, Sprent J, Resting and activated T cells display different requirements for CD8 molecules. J Exp Med 1994; 179:2005-15.
35. + cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int J Cancer 1994; 57:56-62.